Skip to main navigation Skip to search Skip to main content

Frequency and prognostic implications of JAK 1-3 aberrations in Down syndrome acute lymphoblastic and myeloid leukemia

  • M. Blink*
  • , T. D. Buitenkamp
  • , M. M. Van Den Heuvel-Eibrink
  • , A. A. Danen-Van Oorschot
  • , V. De Haas
  • , D. Reinhardt
  • , J. H. Klusmann
  • , M. Zimmermann
  • , M. Devidas
  • , A. J. Carroll
  • , G. Basso
  • , A. Pession
  • , H. Hasle
  • , R. Pieters
  • , K. R. Rabin
  • , S. Izraeli
  • , C. M. Zwaan
  • *Corresponding author for this work
  • Erasmus University Rotterdam
  • Dutch Childhood Oncology Group
  • Hannover Medical School
  • University of Florida
  • University of Alabama at Birmingham
  • Azienda Ospedaliera di Padova
  • University of Bologna
  • Aarhus University
  • Baylor College of Medicine
  • Sheba Medical Center at Tel Hashomer

Research output: Contribution to journalLetterpeer-review

22 Scopus citations
Original languageEnglish
Pages (from-to)1365-1368
Number of pages4
JournalLeukemia
Volume25
Issue number8
DOIs
StatePublished - Aug 2011

Funding

FundersFunder number
National Cancer InstituteU10CA013539

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Cite this